weight regain and cardiometabolic effects after withdrawal of semaglutide maintenance discontinuation GLP-1 therapies Weight regain and cardiometabolic effects

Weight-loss drugs may help people with obesity, but they won't by themselves solve the American obesity crisis, three experts told Newsweek

Clinicians recommend not continuing GLP-1 medication while severe dehydration or other acute medical issues are being treated, and advise follow-up before restarting therapy

Writer & Clinical Content Reviewer Cristina writes content for Treated, and reviews content produced by our other writers to make sure its clinically accurate

Retatrutide, with its glucagon component that increases energy expenditure, may theoretically influence energy levels differently, but clinical trial data on subjective energy has not yet been published in detail

The STEP 1 trial extension The most cited data comes from the STEP 1 trial extension, published in Diabetes, Obesity and Metabolism

I spend almost a billion dollars a year on obesity-related diseases